Skip to main content

Transport of 3-bromopyruvate across the human erythrocyte membrane


3-Bromopyruvic acid (3-BP) is a promising anticancer compound because it is a strong inhibitor of glycolytic enzymes, especially glyceraldehyde 3-phosphate dehydrogenase. The Warburg effect means that malignant cells are much more dependent on glycolysis than normal cells. Potential complications of anticancer therapy with 3-BP are side effects due to its interaction with normal cells, especially erythrocytes. Transport into cells is critical for 3-BP to have intracellular effects. The aim of our study was the kinetic characterization of 3-BP transport into human erythrocytes. 3-BP uptake by erythrocytes was linear within the first 3 min and pH-dependent. The transport rate decreased with increasing pH in the range of 6.0–8.0. The Km and Vm values for 3-BP transport were 0.89 mM and 0.94 mmol/(l cells x min), respectively. The transport was inhibited competitively by pyruvate and significantly inhibited by DIDS, SITS, and 1-cyano-4-hydroxycinnamic acid. Flavonoids also inhibited 3-BP transport: the most potent inhibition was found for luteolin and quercetin.





1-cyano-4-hydroxycinnamic acid




monocarboxylate transporter


4-acetamido-4′-isothiocyanostilbene-2,2′-disulphonic acid


  1. 1.

    Schaefer, N.G., Geschwind, J.F., Engle, J., Buchanan, J.W. and Wahl, R.L. Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma. Transl. Res. 159 (2012) 51–57.

    CAS  PubMed  Article  Google Scholar 

  2. 2.

    Ko, Y.H., Pedersen, P.L. and Geschwind, J.F. Glucose metabolism in the rabbit VX tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett. 173 (2001) 83–91.

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Sánchez-Aragó, M. and Cuezva, J.M. The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil. J. Transl. Med. 9 (2011) 19.

    PubMed Central  PubMed  Article  Google Scholar 

  4. 4.

    Tang, Z., Yuan, S., Hu, Y., Zhang, H., Wu, W., Zeng, Z., Yang, J., Yun, J., Xu, R. and Huang, P. Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-bromopyruvate propyl ester. J. Bioenerg. Biomembr. 44 (2012) 117–125.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  5. 5.

    Queirós, O., Preto, A., Pacheco, A., Pinheiro, C., Azevedo-Silva, J., Moreira, R., Pedro, M., Ko, Y.H., Pedersen, P.L., Baltazar, F. and Casal, M. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate. J. Bioenerg. Biomembr. 44 (2012) 141–153.

    PubMed  Article  Google Scholar 

  6. 6.

    Ko, Y.H., Smith, B.L., Wang, Y., Pomper, M.G., Rini, D.A, Torbenson, M.S., Hullihen, J. and Pedersen, P.L. Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem. Biophys. Res. Commun. 324 (2004) 269–275.

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Ganapathy-Kanniappan, S., Kunjithapatham, R. and Geschwind, J.F. Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting. Anticancer Res. 33 (2013) 13–20.

    CAS  PubMed  Google Scholar 

  8. 8.

    Lea, M.A., Qureshi, M.S., Buxhoeveden, M., Gengel, N., Kleinschmit, J. and Desbordes, C. Regulation of the proliferation of colon cancer cells by compounds that affect glycolysis, including 3-bromopyruvate, 2-deoxyglucose and biguanides. Anticancer Res. 33 (2013) 401–407.

    CAS  PubMed Central  PubMed  Google Scholar 

  9. 9.

    Lis, P., Zarzycki, M., Ko, Y.H., Casal, M., Pedersen, P.L., Goffeau, A. and Ulaszewski, S. Transport and cytotoxicity of the anticancer drug 3-bromopyruvate in the yeast Saccharomyces cerevisiae. J. Bioenerg. Biomembr. 44 (2012) 155–161.

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    Dean, M., Hamon, Y. and Chimini, G. The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res. 42 (2001) 1007–1017.

    CAS  PubMed  Google Scholar 

  11. 11.

    Geschwind, J.F., Ko, Y.H., Torbenson, M.S., Magee, C. and Pedersen, P.L. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res. 62 (2002) 3909–3913.

    CAS  PubMed  Google Scholar 

  12. 12.

    Chang, J.M., Chung, J.W., Jae, H.J., Eh, H., Son, K.R., Lee, K.C. and Park, J.H. Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: In vivo investigation in normal rabbit model. Acad. Radiol. 14 (2007) 85–92.

    PubMed  Article  Google Scholar 

  13. 13.

    Dell’Antone, P. Targets of 3-bromopyruvate, a new, energy depleting, anticancer agent. Med. Chem. 5 (2009) 491–496.

    PubMed  Article  Google Scholar 

  14. 14.

    Sadowska-Bartosz, I. and Bartosz, G. The effect of 3-bromopyruvic acid on human erythrocyte antioxidant defense system. Cell Biol. Int. 2013, in press; DOI: 10.1002/cbin.10160.

    Google Scholar 

  15. 15.

    Dyląg, M., Lis, P., Niedźwiecka, K., Ko, Y.H., Pedersen, P.L., Goffeau, A. and UŁaszewski, S. 3-bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus neoformans. Biochem. Biophys. Res. Commun. 434 (2013) 322–327.

    PubMed  Article  Google Scholar 

  16. 16.

    Janas, T. and Janas, T. Involvement of carboxyl groups in chloride transport and reversible DIDS binding to band 3 protein in human erythrocytes. Cell. Mol. Biol. Lett. 16 (2011) 342–358.

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Kennedy, K.M. and Dewhirst, M.W. Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol. 6 (2010) 127–148.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  18. 18.

    Birsoy, K., Wang, T., Possemato, R., Yilmaz, O.H., Koch, C.E., Chen, W.W., Hutchins, A.W., Gultekin, Y., Peterson, T.R., Carette, J.E., Brummelkamp, T.R., Clish, C.B. and Sabatini, D.M. MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat. Genet. 45 (2013) 104–108.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  19. 19.

    Halestrap, A.P. and Meredith, D. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch. 447 (2004) 619–628.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Dhup, S., Dadhich, R.K., Porporato, P.E. and Sonveaux, P. Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr. Pharm. Des. 18 (2012) 1319–1330.

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Ullah, M.S., Davies, A.J. and Halestrap, A.P. The plasma membrane lactate transporter MsCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J. Biol. Chem. 281 (2006) 9030–9037.

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Draoui, N, and Feron, O. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments. Dis. Model. Mech. 4 (2011) 727–732.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  23. 23.

    Halestrap, A.P. The monocarboxylate transporter family — structure and functional characterization. IUBMB Life 64 (2012) 1–9.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Kunjithapatham, R., Geschwind, J.F., Rao, P.P., Boronina, T.N., Cole, R.N. and Ganapathy-Kanniappan, S. Systemic administration of 3-bromopyruvate reveals its interaction with serum proteins in a rat model. BMC Res. Notes 17 (2013) 277.

    Article  Google Scholar 

  25. 25.

    Belt, J.A., Thomas, J.A., Buchsbaum, R.N. and Racker, E. Inhibition of lactate transport and glycolysis in Ehrlich ascites tumor cells by bioflavonoids. Biochemistry 18 (1979) 3506–3511.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Vaidyanathan, J.B. and Walle, T. Cellular uptake and efflux of the tea flavonoid (-) epicatechin-3-gallate in the human intestinal cell line Caco-2. J. Pharmacol. Exp. Ther. 307 (2003) 745–752.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Di Pietro, A., Conseil, G., Pérez-Victoria, J.M., Dayan, G., Baubichon-Cortay, H., Trompier, D., Steinfels, E., Jault, J.M., de Wet, H., Maitrejean, M., Comte, G., Boumendjel, A., Mariotte, A.M., Dumontet, C., McIntosh, D.B., Goffeau, A., Castanys, S., Gamarro, F. and Barron, D. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell Mol. Life Sci. 59 (2002) 307–322.

    PubMed  Article  Google Scholar 

  28. 28.

    Zhang, S. and Morris, M.E. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J. Pharmacol. Exp. Ther. 304 (2003) 1258–1267.

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Ahmed-Belkacem, A., Pozza, A., Munoz-Martínez, F., Bates, S.E., Castanys, S., Gamarro, F., Di Pietro, A. and Pérez-Victoria, J.M. Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2. Cancer Res. 65 (2005) 4852–4860.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Morris, M.E. and Zhang, S. Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci. 78 (2006) 2116–2130.

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Wang, X., Wolkoff, A.W. and Morris, M.E. Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metab. Dispos. 33 (2005) 1666–1672.

    CAS  PubMed  Article  Google Scholar 

  32. 32.

    Fuchikami, H., Satoh, H., Tsujimoto, M., Ohdo, S., Ohtani, H. and Sawada, Y. Effects of herbal extracts on the function of human organic aniontransporting polypeptide OATP-B. Drug Metab. Dispos. 34 (2006) 577–582.

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Wang, Q. and Morris, M.E. Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. Drug Metab. Dispos. 35 (2007) 201–208.

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Poole, R.C. and Halestrap, A.P. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am. J. Physiol. Cell Physiol. 264 (1993) C761–C782.

    CAS  Google Scholar 

  35. 35.

    Vaihkonen, L.K., Heinonen, O.J., Hyyppa, S., Nieminen, M. and Poso, A.R. Lactate-transport activity in RBCs of trained and untrained individuals from four racing species. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001) R19–R24.

    CAS  PubMed  Google Scholar 

  36. 36.

    Barreca, D., Lagana, G., Tellone, E., Ficarra, S., Leuzzi, U., Galtieri, A. and Bellocco, E. Influences of flavonoids on erythrocyte membrane and metabolic implication through anionic exchange modulation. J. Membr. Biol. 230 (2009) 163–171.

    CAS  PubMed  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Izabela Sadowska-Bartosz.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sadowska-Bartosz, I., Soszyński, M., Ułaszewski, S. et al. Transport of 3-bromopyruvate across the human erythrocyte membrane. Cell Mol Biol Lett 19, 201–214 (2014).

Download citation


  • 3-Bromopyruvic acid
  • Erythrocytes
  • Polyphenols
  • Flavonoids
  • Transport
  • Monocarboxylate transporter
  • 1-Cyano-4-hydroxycinnamic acid
  • Luteolin
  • Quercetin